Here is the full list of the biotech and pharma Startup Battlefield 200 selectees, along with a note on what made us select ...

The "Navigating EU (European Union) and FDA (Food and Drug Administration) Regulations for Drug/Device and Device/Drug Combination Products Training Course (Mar 2nd - Mar 3rd, 2026)" training has been ...

The course offers market opportunities by addressing the need for understanding and implementing the role of the Person Responsible for Regulatory Compliance (PRRC) under MDR and IVDR, critical for ...

Microsoft's AI chief, Mustafa Suleyman, is setting a new course for artificial intelligence. He states Microsoft will stop ...

The tech giant’s AI chief talks about superintelligence “red lines,” why AI will transform medicine and how he unwinds by ...

Microsoft outlines seven AI trends shaping 2026, from secure workplace agents and AI-powered research to hybrid quantum systems redefining computing.

The company hopes to develop specialized AIs that perform at a superhuman level in specific fields without posing existential risks. Share on Facebook (opens in a new window) Share on X (opens in a ...

Background Heart auscultation is a widely used and cost-effective clinical tool for detecting valvular heart disease (VHD), particularly in primary care. However, existing evidence on its diagnostic ...

Microsoft recently unveiled a diagnostic AI system, tested on case studies from the New England Journal of Medicine and benchmarked against practicing physicians, that could significantly enhance ...

The digital health market is growing, and according to Microsoft, its new AI Diagnostic Orchestrator (MAI-DxO) is among the latest in generative, artificial intelligence to support accurate, complex ...

Mustafa Suleyman, CEO of Microsoft’s AI arm, says the tech giant has taken “a genuine step toward medical superintelligence,” Wired reported June 30. In a recent test, Microsoft’s new AI system — ...